These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 773414)

  • 1. The response of psoriasis to betamethasone valerate and clobetasol propionate. A 6-month controlled study.
    Corbett MF
    Br J Dermatol; 1976 Mar; 94 suppl 12():89-93. PubMed ID: 773414
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A comparative, multicenter, double blind trial of 0.05% halobetasol propionate ointment and 0.1% betamethasone valerate ointment in the treatment of patients with chronic, localized plaque psoriasis.
    Blum G; Yawalkar S
    J Am Acad Dermatol; 1991 Dec; 25(6 Pt 2):1153-6. PubMed ID: 1757607
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A double-blind trial of budesonide ointment and betamethasone-17-valerate ointment in psoriasis.
    Schmidt H; Hjorth N; Salde L
    J Int Med Res; 1981; 9(3):236-8. PubMed ID: 7016629
    [TBL] [Abstract][Full Text] [Related]  

  • 4. double-blind"double-bind.
    Björnberg A; Hellgren L
    Curr Med Res Opin; 1975; 3(1):36-8. PubMed ID: 1090417
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A comparison of clobetasol propionate 0.05 percent ointment and an optimized betamethasone dipropionate 0.05 percent ointment in the treatment of psoriasis.
    Jacobson C; Cornell RC; Savin RC
    Cutis; 1986 Mar; 37(3):213-4, 216, 218-20. PubMed ID: 3514155
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A double-blind comparison of quarter strength clobetasol propionate in Unguentum Merck with betamethasone valerate in psoriasis.
    Stankler L
    Br J Clin Pract; 1983; 37(11-12):389-91. PubMed ID: 6367795
    [No Abstract]   [Full Text] [Related]  

  • 7. Efficacy, safety, and cost-effectiveness of all-trans retinoic acid/Clobetasol Propionate Compound Ointment in the treatment of mild to moderate psoriasis vulgaris: A randomized, single-blind, multicenter clinical trial.
    Xia L; Li R; Wang Y; Lin Z; Zheng J; Li X; Lu Q; Zhang J; Jin H; Fu L; Zhang X; Liu Y; Yang S; Xiao F; Gao XH
    Dermatol Ther; 2018 Sep; 31(5):e12632. PubMed ID: 30253049
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasma cortisol values after topical application of diflucortolone valerate (0.3%) or clobetasol propionate (0.05%) in psoriatic patients.
    Keczkes K; Teasdale P; Wiseman RA; Mugglestone CJ
    Br J Dermatol; 1978 Oct; 99(4):417-20. PubMed ID: 361060
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of the response of psoriasis, over a 6-month period, to clobetasol propionate and fluocinolone acetonide ointments.
    Floden CH; Woodbridge P; Samman P; Kurwa AR
    Curr Med Res Opin; 1975; 3(6):375-81. PubMed ID: 1183219
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Local treatment of psoriasis of the scalp with clobetasol propionate and betamethasone-17,21-dipropionate: a double-blind comparison.
    Lassus A
    Curr Med Res Opin; 1976; 4(5):365-7. PubMed ID: 795609
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A study of the comparative efficacy of diflucortolone valerate 0.3% ointment and clobetasol propionate 0.05% ointment.
    Wendt H; Mugglestone CJ; Wiseman RA
    Br J Dermatol; 1978 Oct; 99(4):411-6. PubMed ID: 361059
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combination therapy for psoriasis. Psoralens plus long-wave ultraviolet radiation with betamethasone valerate.
    Hanke CW; Steck WD; Roenigk HH
    Arch Dermatol; 1979 Sep; 115(9):1074-7. PubMed ID: 485184
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Assessment of value and risks of external treatment with clobetasol-17-propionate (Dermovate)].
    van der Harst LC; Smeenk G; Burger PM; van der Rhee HJ; Polano MK
    Ned Tijdschr Geneeskd; 1978 Feb; 122(7):219-23. PubMed ID: 345134
    [No Abstract]   [Full Text] [Related]  

  • 14. Systemic side-effects of three topical steroids in diseased skin.
    Salde L; Lassus A
    Curr Med Res Opin; 1983; 8(7):475-80. PubMed ID: 6226490
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tibicorten and betamethasone valerate: a double-blind comparative study.
    Tazelaar DJ
    J Int Med Res; 1977; 5(5):338-45. PubMed ID: 334605
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Psoriasis treated with clobetasol propionate and photochemotherapy.
    Gould PW; Wilson L
    Br J Dermatol; 1978 Feb; 98(2):133-6. PubMed ID: 343806
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Six-month controlled study of effect of desoximetasone and betamethasone 17-valerate on the pituitary-adrenal axis.
    Cornell RC; Stoughton RB
    Br J Dermatol; 1981 Jul; 105(1):91-5. PubMed ID: 7259982
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clobetasol propionate ointment compared with dithranol in Lassar's paste in the treatment of psoriasis.
    Marriott PJ; Munro DD
    Br J Dermatol; 1976 Mar; 94 suppl 12():101-6. PubMed ID: 1268069
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A double-blind comparison of 1% hydrocortisone plus 10% urea ('Alphaderm') and 0.1% betamethasone 17-valerate in the treatment of non-infective inflammatory dermatoses.
    Khan SA; Williamson DM
    Curr Med Res Opin; 1977-1978; 5(4):354-8. PubMed ID: 343995
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Halomethasone (C 48.401-Ba) for the topical treatment of common dermatoses.
    de la Brassine M; Kint A; Lachapelle JM; Tennstedt D
    J Int Med Res; 1984; 12(5):307-9. PubMed ID: 6238861
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.